Skip to main content
Equibles

Daniel Simon

IDEAYA Biosciences, Inc. (IDYA)

Equibles does not estimate personal net worth.

About Daniel Simon

Daniel Simon has spoken on 1 investor event across 1 company, most recently for IDEAYA Biosciences, Inc. on September 10, 2026. IDEAYA Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at IDEAYA Biosciences, Inc. includes Yujiro Hata (CEO and Board Member), Joshua Bleharski (CFO), Joshua Bleharski, Ph.D. (CFO) and 7 others.

Daniel Simon on recent calls

“So we've got these two collaborations with Roche that we executed early this year. In the first, they are providing their PAN RAS inhibitor, which is a molecular glue, to us to combine with our PRMT5 inhibitor.”
Other, Citi's 2026 Biopharma Back to School Conference ·

Affiliation history

Company network

Leadership on record at IDEAYA Biosciences, Inc.

Recent activity